Cell and Tissue Culture Incubators Market Size & Share, by Type (Direct Heat, Water Jacketed, Air Jacketed); Application (Research, Bio-Production, Diagnostic); End-user (Pharmaceuticals, Biomedical, Academics, IVF Centers) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4050
  • Published Date: Apr 25, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023-2035

Cell And Tissue Culture Incubators Market size is anticipated to reach USD 5 Billion by the end of 2035, growing at a CAGR of 7% during the forecast period, i.e., 2023-2035. In the year 2022, the industry size of cell and tissue culture incubators was over USD 3 Billion. The growth of the market can be attributed to the increasing number of chronic diseases. The desire for novel medicines and treatments is being driven by the rising prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders. For instance, several of these therapies are based on cell and gene therapies, which call for the utilization of sophisticated cell culture methods and premium incubation equipment. By 2030, there will be over 40 million more Americans who suffer from chronic illnesses.

In addition to these, factors that are believed to fuel the market growth of cell and tissue culture incubators include the rise in technological advancements. Technology advancements have resulted in the creation of more advanced cell and tissue culture incubators. For instance, some incubators now come equipped with enhanced imaging capabilities, and remote monitoring, which are increasing the demand in industrial and research environments.


Cell and Tissue Culture Incubators Market
Get more information on this report: Request Free Sample PDF

Cell and Tissue Culture Incubators Sector: Growth Drivers and Challenges

Growth Drivers

  • Growing Pharmaceutical Sector – On account of the expanding pharmaceutical industry, the need for cell and tissue culture incubators is expected to rise, as incubators are a necessary piece of equipment for pharmaceutical research and development. Globally, the pharmaceutical industry in India is valued at over USD 40 billion. The Indian pharmaceutical market expanded by 17% yearly in 2021.
  • Rising Geriatric Population – Owing to the necessity for research and drug development in age-related disorders as well as the expanding interest in regenerative medicine, the need for cell and tissue culture incubators is projected to increase as the older population grows. Lately over 8 % of the world's population, is over the age of 65. This number is anticipated to increase to over 15% of the global population by 2050.
  • Increasing Health Spending – Probably, the need for cell and tissue culture incubators to assist the research will increase owing to an increase in health spending across the globe. According to the most recent expenditure data, in 2021, health spending in the US increased by over 2%.
  • Growing Drug Development – It is expected that more cell and tissue culture incubators might be required as new medications are created and made available, which is anticipated to drive market growth. According to statistics, the top 20 pharmaceutical corporations around the globe invest over USD 50 billion annually in medication development.

Challenges

  • Potential for a Critical Error- The possibility of errors is one of the major factors predicted to slow down the market growth. For instance, the growth and viability of cell and tissue cultures can be impacted by changes in temperature, humidity, and other environmental conditions.  In addition, critical errors can also affect the integrity of experimental findings and result in erroneous inferences, both of which can be detrimental to the research project.
  • High Price of Incubators
  • Standardization Issues in High-Volume Production

Cell and Tissue Culture Incubators Market: Key Insights

Base Year

2022

Forecast Year

2023-2035

CAGR

~7%

Base Year Market Size (2022)

~ USD 3 Billion

Forecast Year Market Size (2035)

~ USD 5 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Cell and Tissue Culture Incubators Segmentation

End-user (Pharmaceuticals, Biomedical, Academics, IVF Centers)

The cell and tissue culture incubators market is segmented and analyzed for demand and supply by end-user into pharmaceuticals, biomedical, academics, and IVF centers. Out of the four end-users of cell and tissue culture incubators, the IVF centers segment is estimated to gain the largest market share in the year 2035. The growth of the segment can be attributed to the growing frequency of IVF treatments being carried out. The demand for premium cell culture incubators is growing along with the number of IVF treatments. For instance, in IVF centers, cell culture incubators are crucial equipment for growing and keeping embryos in a controlled environment. In addition, the embryos are often cultivated in a lab for a few days before being transferred to boost the chances of success. Cell culture incubators are necessary to maintain the best conditions possible for the embryos to develop and thrive during this process. According to statistics, approximately 2 million IVF procedures are carried out annually throughout the world.

Application (Research, Bio-Production, Diagnostic)

The  cell and tissue culture incubators market is also segmented and analyzed for demand and supply by application into research, bioproduction, and diagnostics. Amongst these three segments, the research pharmacies segment is expected to garner a significant share in the year 2035. Incubators for cell and tissue culture are necessary instruments for preserving and developing cells and tissues in a controlled environment, which is critical for a variety of research applications. For instance, scientists employ cell culture methods to examine the effects of various medications, evaluate the efficacy and safety of novel treatments, and look into the molecular causes of disease. This, as a result, is anticipated to create numerous opportunities for the growth of the segment in the coming years.

Our in-depth analysis of the global market includes the following segments:

      By Type

  • Direct Heat
  • Water Jacketed
  • Air Jacketed

      By Application

  • Research
  • Bio-Production
  • Diagnostic

      By End User

  • Pharmaceuticals
  • Biomedical
  • Academics
  • IVF Centers

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Cell and Tissue Culture Incubators Industry - Regional Synopsis

North American Market Forecast

The market share of cell and tissue culture incubators in North America, amongst the market in all the other regions, is projected to be the largest with a share of about ~35% by the end of 2035. The growth of the market can be attributed majorly to the increasing frequency of diseases such as cancer. There will would be a greater need for cancer research and treatment development owing to rising cancer cases in the region. In consequence, it is anticipated that this would result in an increased demand for cell and tissue culture incubators. For instance, cell and tissue culture incubators are widely used in cancer research and medication development since they provide the ideal conditions for cell and tissue growth and preservation. Further, the growing technological advancements in the region, along with the availability of a large number of incubators manufacturers, are also anticipated to contribute to the market growth in the region. In addition, the growing demand at research institutes and centers for cutting-edge cell culture incubators in the region is also anticipated to boost market growth during the forecast period. In the United States, there were over 609,000 cancer deaths and an estimated 1 million newly diagnosed cancer cases in 2022.

Europe Market Forecast

The European cell and tissue culture incubators market is estimated to hold the second-largest share by the end of 2035. The growth of the market can be attributed majorly to the enhanced flexibility in government rules and regulations for the region's research operations. Research institutions in the area can undertake research and development more effectively and with a less regulatory burden as government laws and regulations are more flexible. As a result, researchers are likely to have easier access to financing and resources for their further studies, which may increase the demand for cell and tissue culture incubators. Further, the favorable regulatory standards in the region, along with the growing biotech and pharmaceutical industry, are also anticipated to contribute to the market growth in the region.

APAC Market Statistics

Further, the market in the Asia Pacific region, amongst the market in all the other regions, is projected to hold a majority of the share by the end of 2035. The growth of the market can be attributed majorly to the increasing focus on cell culture-based vaccine production. For instance, the demand for specialist equipment, including incubators, is projected to rise as more biotech and pharmaceutical firms in the area turn to cell culture-based approaches for vaccine production. Further, the growing awareness of cell and gene therapy in the region, along with the increasing popularity of scientific technologies, is also anticipated to contribute to the market growth in the region.

Research Nester
Cell and Tissue Culture Incubators Market Size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Cell and Tissue Culture Incubators Landscape

top-features-companies
    • Thermo Fisher Scientific Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Memmert Gmbh+ Co. KG
    • BINDER GmbH
    • PHC Holdings Corporation
    • Sheldon Manufacturing INC
    • Bionics Scientific Technologies (P) Ltd
    • BioSpherix, Ltd.
    • Adolf Kühner AG
    • Acmas Technologies Inc.
    • Cole-Parmer Instrument Company, LLC

In the News

  • Thermo Fisher Scientific Inc. introduced the Thermo Scientific DynaSpin Single-Use Centrifuge system to offer the best single-use answer for extensive cell culture collection. Further, by the use of fewer depth filtering cartridges, the DynaSpin technology enhances and streamlines harvesting for cell culture separation in single-use bioprocesses.
  • PHC Holdings Corporation teamed up with Univercells Technologies to introduce scale-X for gene therapy and regenerative medicine development. Furthermore, the scale-X portfolio provides comparable fluid conditions across all scales, guaranteeing consistent cell and product activity.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4050
  • Published Date: Apr 25, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising geriatric population and the growing drug development are the major factors driving the market growth.

The market size of cell and tissue culture incubators is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2023-2035.

High price of incubators and the potential for a critical error are estimated to be the growth-hindering factors for the market expansion.

The market in the North American region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.

The major players in the market are Thermo Fisher Scientific Inc., Bionics Scientific Technologies (P) Ltd., BioSpherix, Ltd, Adolf Kühner AG, Acmas Technologies Inc., Cole-Parmer Instrument Company, LLC, Sheldon Manufacturing, Inc., and others.

The company profiles are selected based on the revenues generated from the product segment, the geographical presence of the company which determines the revenue generating capacity as well as the new products being launched into the market by the company.

The market is segmented by type, application, end-user, and by region.

The IVF Centers segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.
Cell and Tissue Culture Incubators Market Report Scope
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying